insights_auto
Outlook: 79.0% bullish·0.0% bearish
Go to analysischevron_right
HAE:NYSE
Haemonetics Corp
120,84 US$
arrow_upward
+1,82%(+2,15) 1D
12 ოქტ, 10:06:00 GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for HAE...
Open
118,70 US$
High
120,84 US$
Low
118,36 US$
Mkt. cap
5,50 მლრდ.
Avg. vol.
668,91 ათ.
Volume
109,29 ათ.
P/E ratio
58,94
52-wk high
121,19 US$
52-wk low
48,55 US$
EPS
2,05 US$
Beta
0,61
Shares outstanding
45,50 მლნ.
No. of employees
3 ათ.
Open
118,70 US$
High
120,84 US$
Low
118,36 US$
Mkt. cap
5,50 მლრდ.
Avg. vol.
668,91 ათ.
Volume
109,29 ათ.
P/E ratio
58,94
52-wk high
121,19 US$
52-wk low
48,55 US$
EPS
2,05 US$
Beta
0,61
Shares outstanding
45,50 მლნ.
No. of employees
3 ათ.
News stories
From web sources and news partners
Simply Wall Street
·
3 დღის წინ
Full U.S. Rollout Could Change The Case For Haemonetics Stock
Profile
Haemonetics Corporation is a global provider of blood and plasma supplies and services. The company was founded in Natick, Massachusetts by Dr. Allen Latham in the 1970s.
Today, the company has expanded and has offices located in 16 countries. The company employs more than 1,800 people and markets its products in over 50 countries. Revenue is derived nearly equally from its three major markets -- Asia, Europe, and the Americas. Wikipedia
About Haemonetics Corp
CEOქრისტოფერ საიმონ
Employees3,01 ათ.
Founded1971
Headquartersბოსტონი, მასაჩუსეტსი, ამერიკის შეერთებული შტატები
SectorMedical device
Websitehaemonetics.com